| Identification | Back Directory | [Name]
FGFR4-IN-4 | [CAS]
2230973-67-6 | [Synonyms]
FGFR4-IN-4
FGFR-4-IN-4,FGFR4 IN 4,FGFR4IN4
2-Propenamide, N-[(3R,4S)-4-[[6-(2,6-dichloro-3,5-dimethoxyphenyl)-8-(4-methoxy-1-piperidinyl)pyrido[3,4-d]pyrimidin-2-yl]amino]tetrahydro-3-furanyl]- | [Molecular Formula]
C28H32Cl2N6O5 | [MDL Number]
MFCD32664429 | [MOL File]
2230973-67-6.mol | [Molecular Weight]
603.5 |
| Hazard Information | Back Directory | [Uses]
FGFR4-IN-4 (compound 693) is a FGFR4 inhibitor with anti-tumor activity, extracted from patent WO2018113584A1[1]. | [IC 50]
FGFR4 | [References]
[1] YANG, Fei, et al. FGFR4 INHIBITOR, PREPARATION METHOD THEREFOR AND PHARMACEUTICAL USE THEREOF. WO2018113584A1. |
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 |
| Website: |
https://www.weikeqi-biotech.com/ |
|